As a co-founder of Flagship Biosciences, Trevor Johnson has been instrumental to the continued success of the company both in his current position as Chief Executive Officer and previously as Chief Operating Officer. He possesses a deep understanding of the biomarkers and data analytics space with previous experience as a Sr. Global Image Analysis Specialist at Aperio and a Software Engineer (Image Analysis) at Apogen Technologies (aka QientiQ North America).

Trevor earned his bachelor’s degree from Boston University and master’s from UCLA both in Electrical Engineering.